Novo Nordisk Pharmaceuticals

Novo Nordisk is a world-renowned multinational pharmaceutical and healthcare company headquartered in Bagsværd, Denmark. The company traces its origins back to 1923 when Nordisk Insulinlaboratorium was founded, followed closely by Novo Terapeutisk Laboratorium in 1925. The two pioneering Danish entities merged in 1989 to establish Novo Nordisk, creating a global leader in diabetes care, weight management, and other serious chronic conditions.

The iconic Apis bull emblem seen in the logo has represented the Novo brand since the 1920s, drawing inspiration from ancient Egyptian iconography associated with life and healing. Today, the majority voting rights of the publicly traded company are held by the Novo Nordisk Foundation through its investment arm, Novo Holdings A/S, ensuring long-term Danish ownership and a dedicated philanthropic mission.

Novo Nordisk maintains major production hubs in Denmark—including Kalundborg, Hillerød, and Bagsværd—alongside extensive manufacturing facilities in the United States, France, Brazil, and China to supply life-saving medications worldwide.